COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026
09/06/2026
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Applied Biologics Receives FDA Clearance to Advance BIOxHEAL Into Phase 3 Clinical Development for Diabetic Foot Ulcers
09/06/2026
SCOTTSDALE, Ariz., June 09, 2026 (GLOBE NEWSWIRE) -- Applied Biologics , a biopharmaceutical company developing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, today announced that [...]
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS
09/06/2026
PRESS RELEASE AB SCIENCE IS INVITED TO PRESENT AT THE 2026 ENCALS ANNUAL MEETING THE SURVIVAL DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS Masitinib treatment has been linked to a 5-year [...]
AB Science présentera, lors du congrès annuel 2026 de l'ENCALS, les données de survie issues du programme clinique du masitinib dans la SLA
09/06/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE PRÉSENTERA, LORS DU CONGRÈS ANNUEL 2026 DE L'ENCALS, LES DONNÉES DE SURVIE ISSUE DU PROGRAMME CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Le traitement avec le masitinib [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026
09/06/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer
09/06/2026
PRESS RELEASE, 06/09/2026, 08:00 CDT Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer Itasca, IL, US, 09 June 2026 – Today, [...]
AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
09/06/2026
Acquisition strengthens end-to-end support for Limited English Proficiency (LEP) patients by pairing high-quality AI assistance with AMN’s trusted human interpreter services DALLAS, June 09, 2026 (GLOBE NEWSWIRE) -- AMN [...]
Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year
09/06/2026
WICHITA, Kan., June 09, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living ® has earned Great Place to Work ® Certification ™ for the eighth consecutive year, a distinction based entirely on feedback from associates through [...]
Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand
09/06/2026
The partnership brings Nucleus’ advanced carrier and embryo screening to Hawaii’s largest IVF practice NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today announced an IVF+ partnership with the Fertility [...]
FDA Expands Sunscreen Options for the First Time in 20 Years
09/06/2026
Silver Spring, Md., June 09, 2026 (GLOBE NEWSWIRE) -- Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency' [...]
Ally Medical ER Is Coming to Magnolia
09/06/2026
A new 24/7 emergency room is coming to Montgomery County's fastest-growing community, designed with local families in mind MAGNOLIA, Texas, June 09, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room has announced [...]
Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
09/06/2026
BEDMINSTER, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics, LLC announces the acquisition of NUVESSA ® (metronidazole vaginal gel 1.3%), an FDA-approved prescription medication indicated for the treatment [...]
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
09/06/2026
MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Koi Peptides Survey Finds 75% of Lab Researchers Cite Sourcing Quality as Top Concern
09/06/2026
Cheyenne, WY, June 09, 2026 (GLOBE NEWSWIRE) -- A new Koi Peptides survey of 412 laboratory researchers found that 75% rank sourcing quality among their top concerns when buying research peptides, placing it above price [...]
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
09/06/2026
OCALA, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”), today announced that it has entered into definitive agreements for a registered direct offering and [...]
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board
09/06/2026
World-renowned neuroscientist, Dean of the Icahn School of Medicine at Mount Sinai, and longtime BPGbio’s SAB member, appointed Chair of the SAB, succeeding Chas Bountra, Ph.D., who recently transitioned to Chief [...]
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
09/06/2026
COPD study initiation expands WIN378 development into a second major respiratory disease WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half [...]
Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle
09/06/2026
Company Continues Delivering on Aggressive 2026 Expansion Strategy as Production Scale Reaches New Heights ANN ARBOR, Mich., June 09, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the [...]
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
09/06/2026
$13.5 million financing, including $5 million from Corvus, supports ongoing generation of soquelitinib clinical data in China for atopic dermatitis and asthma, which are indications also in development by Corvus in the [...]

Pages